8-K
filed July 1, 2024, 7:59 PM ET
ticker BNTC
CIK 0001808898
leadership
confidence high
sentiment positive
materiality 0.50
Benitec appoints Kishen Mehta to board; Suvretta Capital portfolio manager
Benitec Biopharma Inc.
- Appointed as Class I director effective June 26, 2024, term through 2026 annual meeting.
- Mehta is portfolio manager at Suvretta Capital, which led $40M PIPE financing in April 2024.
- Will serve on Nominating and Corporate Governance Committee; board deemed him independent.
- Also serves on Biohaven Pharmaceuticals board; 15+ years healthcare investing experience.
- Appointment follows Board Designation Agreement with Suvretta disclosed in prior 8-K.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-24-173338
- form_type
- 8-K
- ticker
- BNTC
- cik
- 0001808898
- company_name
- Benitec Biopharma Inc.
- filed_at
- 2024-07-01T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:14.600560+00:00
- generated_at
- 2026-06-01T00:06:11.210765+00:00
- sec_items
- ["5.02", "9.01"]
- event_type
- leadership
- sentiment
- positive
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-24-173338
- json_url
- https://secwatch.observer/filing/0001193125-24-173338.json
- markdown_url
- https://secwatch.observer/filing/0001193125-24-173338.md
- text_url
- https://secwatch.observer/filing/0001193125-24-173338.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1808898/000119312524173338/0001193125-24-173338-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1808898/000119312524173338/d853226d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
TKNO
Alpha Teknova director Irene Davis to retire; board reduced from 8 to 7; shareholder votes approved nominees and auditor
Alpha Teknova, Inc.
June 1, 2026, 5:22 PM ET
leadership
Items 5.02, 5.07, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On June 26, 2024, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed Kishan (“Kishen”) Mehta to serve as a director of the Board, effective as of June 26, 2024.
Comparable filing
On May 27, 2026, Irene Davis, a member of the Board of Directors (the “Board”) of Alpha Teknova, Inc. (the “Company”) and a member of the Nominating and Corporate Governance Committee, notified the Company of her intention not to stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “Meeting”) and to retire from the Board and all committees thereof, effective upon the date of the Meeting.
Filing page
SEC filing
WTTR
Select Water Solutions COO Skarke moves to Chief Commercial Officer; no successor named
Select Water Solutions, Inc.
June 1, 2026, 5:00 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On June 26, 2024, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed Kishan (“Kishen”) Mehta to serve as a director of the Board, effective as of June 26, 2024.
Comparable filing
Effective June 1, 2026, Michael C. Skarke transitioned from serving as the Executive Vice President and Chief Operating Officer of Select Water Solutions, Inc. (the “Company”) to serving as the Company’s Executive Vice President and Chief Commercial Officer,
Filing page
SEC filing
LPX
LP Building Solutions announces CFO succession: Alan Haughie to retire; Aaron Howald named CFO effective Sept 1, 2026
LOUISIANA-PACIFIC CORP
June 1, 2026, 4:31 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On June 26, 2024, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed Kishan (“Kishen”) Mehta to serve as a director of the Board, effective as of June 26, 2024.
Comparable filing
On May 27, 2026, Alan J.M. Haughie, Executive Vice President and Chief Financial Officer of Louisiana-Pacific Corporation (“LP”, the “Company”), notified the Board of Directors of LP (the “Board”) of his intention to retire from the role of Executive Vice President and Chief Financial Officer, effective September 1, 2026.
Filing page
SEC filing
LOGC
ContextLogic appoints Scott Stewart as CFO & COO effective June 1; interim CFO resigns
ContextLogic Holdings Inc.
June 1, 2026, 4:15 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On June 26, 2024, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed Kishan (“Kishen”) Mehta to serve as a director of the Board, effective as of June 26, 2024.
Comparable filing
On June 1, 2026 the Company also announced the appointment of Scott Stewart, age 53, as Chief Financial Officer and Chief Operating Officer, effective June 1, 2026 (the “Effective Date”).
Filing page
SEC filing
VMI
Former CFO Thomas Liguori enters separation agreement; $4.9M retirement benefits
VALMONT INDUSTRIES INC
June 1, 2026, 4:15 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On June 26, 2024, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed Kishan (“Kishen”) Mehta to serve as a director of the Board, effective as of June 26, 2024.
Comparable filing
Valmont Industries Inc. previously reported the appointment of John Schwietz as Valmont’s Executive Vice President and Chief Financial Officer and Corporate Secretary, effective April 8, 2026, to succeed Thomas Liguori.
Filing page
SEC filing
PSQH
PSQ Holdings SVP of People Michael Hebert resigns; severance of $137,500
PSQ Holdings, Inc.
June 1, 2026, 4:02 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On June 26, 2024, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed Kishan (“Kishen”) Mehta to serve as a director of the Board, effective as of June 26, 2024.
Comparable filing
On May 26, 2026, Michael Hebert resigned from his position of Senior Vice President of People of PSQ Holdings, Inc. (the “Company”), effective May 31, 2026.
Filing page
SEC filing
MGNO
Magnolia Bancorp names Robert Kimbro President/CEO; Hurley becomes Executive Chair
Magnolia Bancorp, Inc.
June 1, 2026, 2:15 PM ET
leadership
Items 5.02, 5.07, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On June 26, 2024, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed Kishan (“Kishen”) Mehta to serve as a director of the Board, effective as of June 26, 2024.
Comparable filing
On May 28, 2026, both the Company and the Association appointed Robert W. Kimbro as their President and Chief Executive Officer effective as of June 1, 2026.
Filing page
SEC filing
FSBW
FS Bancorp names Matt Mullet CEO as planned; Joe Adams retires but stays on board
FS Bancorp, Inc.
June 1, 2026, 11:31 AM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On June 26, 2024, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed Kishan (“Kishen”) Mehta to serve as a director of the Board, effective as of June 26, 2024.
Comparable filing
it has named Matthew D. Mullet as Chief Executive Officer of the Company effective June 1, 2026
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.